Nexelis services

For R&D in Immunogenicity, Immuno-Oncology, and Cell and Gene Therapy. We have exceptional in vitro bioassay development services and support for early evaluation and screening of candidate therapeutics. Our highly experienced team will facilitate in silico immunogenicity assessment with epitope prediction to in vitro immunogenicity and immuno-functionality assays.

Custom In Vivo Models and Testing Solutions. Selecting the appropriate in vivo model for your assays is critical for the success of your preclinical research program. At Nexelis, a Q² Solutions Company, we designed and developed disease specific in vivo models alongside bespoke personalized model development services. Our wealth of experience and capabilities allows us to help answer our clients’ research questions and aid with the most appropriate study design. We provide non-regulated, preclinical development solutions that include performing experiments, analysis, reporting, and technical writing.

Molecular Biology and Protein Expression, Purification, and Characterization. When you partner with the Nexelis, a Q² Solutions Company, we will work closely with you from concept through delivery. Our services are fully flexible according to your needs and can be engaged as stand-alone tests or as a comprehensive package. You receive proteins tailored to your specifications in scale, purity, activity, and other analytical characteristics — on a timeline that meets your needs.

Including Pharmacokinetics and Immunogenicity. Designed to be an extension of your laboratory, Nexelis, a Q² Solutions Company, supports bioanalysis in all phases with agile assay development to validation mindset. Whether we design a custom bioanalytical assay or support a client’s technology transfer, our method development process results in an optimized assay compliant with global standards. Our organization commits to continued investment and development in bioanalytical methods. Clients in the pharmaceutical, biotech, and animal health industries rely on us for the complete range of comprehensive bioanalytical services for all modalities.

Testing Services to Support Your Preclinical and Phase I-IV Drug Programs. Nexelis, a Q² Solutions Company, provides biomarker assay services in inflammation and immunology, oncology, organ injury (renal), nutritional health, cardiovascular, metabolic (NASH/NAFLD) and infectious diseases. Our scientists approach your projects with flexible and creative solutions, developing fit-for-purpose to validated assays that support your protocol.